Evidence map›Paper›PMID 36077727›Full record

ArticleCancers2022

Cancerous Tumor Controlled Treatment Using Search Heuristic (GA)-Based Sliding Mode and Synergetic Controller.

Fazal Subhan, Muhammad Adnan Aziz, Inam Ullah Khan, Muhammad Fayaz, Marcin Wozniak, Jana Shafi, Muhammad Fazal Ijaz

Abstract read
In one paragraph

Article in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Ginsenoside Rg2 fromMolecules (Basel, Switzerland) · 2026
    Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Fazal SubhanDepartment of Electronic Engineering, School of Engineering and Applied Sciences (SEAS), Isra University Islamabad Campus, Islamabad 44000, Pakistan.
Muhammad Adnan AzizDepartment of Electronic Engineering, School of Engineering and Applied Sciences (SEAS), Isra University Islamabad Campus, Islamabad 44000, Pakistan.ORCID 0000-0002-4658-1133
Inam Ullah KhanDepartment of Electronic Engineering, School of Engineering and Applied Sciences (SEAS), Isra University Islamabad Campus, Islamabad 44000, Pakistan.
Muhammad FayazDepartment of Computer Science, University of Central Asia, Naryn 722600, Kyrgyzstan.
Marcin WozniakFaculty of Applied Mathematics, Silesian University of Technology, 44-100 Gliwice, Poland.ORCID 0000-0002-9073-5347
Jana ShafiDepartment of Computer Science, College of Arts and Science, Prince Sattam bin Abdul Aziz University, Wadi Ad-Dawasir 11991, Saudi Arabia.ORCID 0000-0001-6859-670X
Muhammad Fazal IjazDepartment of Intelligent Mechatronics Engineering, Sejong University, Seoul 05006, Korea.ORCID 0000-0001-5206-272X

Funding

Rector of the Silesian University of Technology, Gliwice,Poland 09/010/RGJ22/0068
6 · The paper itself

Abstract

Cancerous tumor cells divide uncontrollably, which results in either tumor or harm to the immune system of the body. Due to the destructive effects of chemotherapy, optimal medications are needed. Therefore, possible treatment methods should be controlled to maintain the constant/continuous dose for affecting the spreading of cancerous tumor cells. Rapid growth of cells is classified into primary and secondary types. In giving a proper response, the immune system plays an important role. This is considered a natural process while fighting against tumors. In recent days, achieving a better method to treat tumors is the prime focus of researchers. Mathematical modeling of tumors uses combined immune, vaccine, and chemotherapies to check performance stability. In this research paper, mathematical modeling is utilized with reference to cancerous tumor growth, the immune system, and normal cells, which are directly affected by the process of chemotherapy. This paper presents novel techniques, which include Bernstein polynomial (BSP) with genetic algorithm (GA), sliding mode controller (SMC), and synergetic control (SC), for giving a possible solution to the cancerous tumor cells (CCs) model. Through GA, random population is generated to evaluate fitness. SMC is used for the continuous exponential dose of chemotherapy to reduce CCs in about forty-five days. In addition, error function consists of five cases that include normal cells (NCs), immune cells (ICs), CCs, and chemotherapy. Furthermore, the drug control process is explained in all the cases. In simulation results, utilizing SC has completely eliminated CCs in nearly five days. The proposed approach reduces CCs as early as possible.

Indexed as

Bernstein polynomial (bsp)chemotherapygenetic algorithm (ga)immunotherapy and optimizationnonlinear ordinary coupled differential equation (ncode)sliding mode controller (smc)synergetic controller (sc)

Identifiers

PMID36077727
PMCPMC9454425

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.